Cover Image

Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP): a single center, open-label, three-arm, randomized, controlled intervention trial

Liver cirrhosis is a major healthcare problem and the mortality rate is high. During recent years, systemic inflammation has been recognized as a major driver of hepatic decompensation and progression of liver cirrhosis to acute-on-chronic liver failure (ACLF). The aim of the CYTOHEP study is to ass...

Full description

Saved in:
Bibliographic Details
Main Authors: Sekandarzad, Asieb (Author) , Weber, Enya (Author) , Prager, Eric Peter (Author) , Graf, Erika (Author) , Bettinger, Dominik (Author) , Wengenmayer, Tobias (Author) , Supady, Alexander (Author)
Format: Article (Journal)
Language:English
Published: 18 March 2022
In: Trials
Year: 2022, Volume: 23, Pages: 1-20
ISSN:1468-6694
DOI:10.1186/s13063-022-06139-6
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13063-022-06139-6
Get full text
Author Notes:Asieb Sekandarzad, Enya Weber, Eric Peter Prager, Erika Graf, Dominik Bettinger, Tobias Wengenmayer and Alexander Supady
Description
Summary:Liver cirrhosis is a major healthcare problem and the mortality rate is high. During recent years, systemic inflammation has been recognized as a major driver of hepatic decompensation and progression of liver cirrhosis to acute-on-chronic liver failure (ACLF). The aim of the CYTOHEP study is to assess the impact of extracorporeal hemoadsorption with the CytoSorb adsorber on serum bilirubin concentrations, humoral inflammation parameters, liver function parameters, and patient survival in patients with ACLF and acute kidney injury (AKI).
Item Description:Gesehen am 13.05.2022
Physical Description:Online Resource
ISSN:1468-6694
DOI:10.1186/s13063-022-06139-6

Similar Items